Liangping Xia

888 total citations
45 papers, 691 citations indexed

About

Liangping Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Liangping Xia has authored 45 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Liangping Xia's work include Colorectal Cancer Treatments and Studies (12 papers), Head and Neck Cancer Studies (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Liangping Xia is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Head and Neck Cancer Studies (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Liangping Xia collaborates with scholars based in China and United States. Liangping Xia's co-authors include Wenzhuo He, Chang Jiang, Bei Zhang, Huijuan Qiu, Chenxi Yin, Guifang Guo, Xuxian Chen, Fang Wang, Yan Wang and Shaodong Hong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Liangping Xia

43 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangping Xia China 15 443 225 165 158 105 45 691
Campbell SD Roxburgh United Kingdom 8 797 1.8× 237 1.1× 270 1.6× 230 1.5× 42 0.4× 22 924
Hironaga Satake Japan 18 667 1.5× 156 0.7× 372 2.3× 573 3.6× 97 0.9× 147 1.1k
Xin An China 15 839 1.9× 201 0.9× 423 2.6× 183 1.2× 58 0.6× 29 1.0k
Su Jung Shim South Korea 14 294 0.7× 145 0.6× 303 1.8× 156 1.0× 40 0.4× 34 819
Xinguo Xiong China 9 216 0.5× 108 0.5× 182 1.1× 413 2.6× 89 0.8× 13 689
Virginia Arrazubi Spain 12 372 0.8× 109 0.5× 155 0.9× 235 1.5× 136 1.3× 48 641
Jennifer A. Dorth United States 15 371 0.8× 76 0.3× 248 1.5× 272 1.7× 162 1.5× 60 837
Xiaobo He China 7 412 0.9× 166 0.7× 81 0.5× 215 1.4× 79 0.8× 8 561
Toshiro Yonei Japan 10 540 1.2× 102 0.5× 90 0.5× 503 3.2× 85 0.8× 28 855

Countries citing papers authored by Liangping Xia

Since Specialization
Citations

This map shows the geographic impact of Liangping Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangping Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangping Xia more than expected).

Fields of papers citing papers by Liangping Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangping Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangping Xia. The network helps show where Liangping Xia may publish in the future.

Co-authorship network of co-authors of Liangping Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Liangping Xia. A scholar is included among the top collaborators of Liangping Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangping Xia. Liangping Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Lulu, Guoliang Fan, Hang Xie, et al.. (2025). Maternal–to–neonatal microbial transmission and impact of prenatal probiotics on neonatal gut development. Journal of Translational Medicine. 23(1). 1198–1198. 1 indexed citations
2.
3.
4.
Zhou, Fuxiang, Hui Xu, Chao Jiang, et al.. (2023). Efficacy and Safety of High-Dose Vitamin C Combined with Total Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer (HCCSC R02 Study). International Journal of Radiation Oncology*Biology*Physics. 117(2). e291–e292. 1 indexed citations
5.
Wang, Daquan, Bo Qiu, Qianwen Liu, et al.. (2023). Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3400–3413. 18 indexed citations
6.
Yu, Hui, Ping Chen, Liangping Xia, et al.. (2021). PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 9(11). e003431–e003431. 10 indexed citations
7.
Liu, Shousheng, Chang Jiang, Lin Yang, et al.. (2020). First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study. Scientific Reports. 10(1). 12336–12336. 8 indexed citations
8.
9.
He, Wenzhuo, Chang Jiang, Lili Liu, et al.. (2020). Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer. Oral Oncology. 108. 104771–104771. 26 indexed citations
10.
Wang, Fang, Wenzhuo He, Chang Jiang, et al.. (2018). Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. BMC Cancer. 18(1). 1102–1102. 30 indexed citations
11.
Quan, Qi, Yuanyuan Huang, Huijuan Qiu, et al.. (2017). Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis. Translational Oncology. 10(2). 288–294. 20 indexed citations
12.
He, Wenzhuo, Chang Jiang, Pengfei Kong, et al.. (2017). Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients. Journal of Cancer. 8(3). 388–394. 22 indexed citations
13.
14.
Jiang, Chang, Xiuyu Cai, Hongxia Zhang, et al.. (2017). Activity and Immune Correlates of a Programmed Death-1 Blockade Antibody in the treatment of Refractory Solid Tumors. Journal of Cancer. 9(1). 205–212. 8 indexed citations
15.
Jiang, Chang, Wanming Hu, Qiong Yang, et al.. (2016). Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients. OncoTargets and Therapy. 9. 877–877. 15 indexed citations
16.
Xia, Liangping, Yan Wang, Shaodong Hong, et al.. (2016). Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis. PLoS ONE. 11(7). e0158853–e0158853. 59 indexed citations
17.
Jiang, Chang, Yuming Rong, Qiong Yang, et al.. (2014). Efficacy of Taxane-Based Regimens in a First-line Setting for Recurrent and/or Metastatic Chinese Patients with Esophageal Cancer. Asian Pacific Journal of Cancer Prevention. 15(13). 5493–5498. 5 indexed citations
18.
He, Wenzhuo, Chang Jiang, Chenxi Yin, et al.. (2014). Prognostic Model Built on Blood-based Biomarkers in Patients with Metastatic Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(17). 7327–7331. 9 indexed citations
19.
He, Wenzhuo, Chenxi Yin, Guifang Guo, et al.. (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Medical Oncology. 30(1). 439–439. 162 indexed citations
20.
Xia, Liangping, Bei Zhang, Xuxian Chen, et al.. (2009). Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases. Chinese Journal of Cancer. 28(9). 977–982. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Campbell SD Roxburgh Breakdown of academic impact, for papers by Hironaga Satake Breakdown of academic impact, for papers by Xin An Breakdown of academic impact, for papers by Su Jung Shim Breakdown of academic impact, for papers by Xinguo Xiong Breakdown of academic impact, for papers by Virginia Arrazubi Breakdown of academic impact, for papers by Jennifer A. Dorth Breakdown of academic impact, for papers by Xiaobo He Breakdown of academic impact, for papers by Toshiro Yonei
Rankless by CCL
2026